Abstract:We have previously found that expression of MARVELD1 was remarkably downregulated in multiple tumor tissues, but unclear in hepatocellular carcinoma (HCC) and its function has not been explored yet. In the present study, to uncover the underlying mechanism of MARVELD1 in the pathogenesis and development of HCC, we investigated the expression pattern of MARVELD1 and its effect on tumor proliferation in HCC. The results indicated the frequent downregulation of MARVELD1 in clinic samples and cell lines of HCC resulted from promoter methylation, as well as genetic deletion. Furthermore, treatment of MARVELD1 unexpressing Hep3B2.1-7 and PLC/PRF/5 cells with the demethylating agent 5-aza-2' deoxycytidine restored its expression. Overexpression of MARVELD1 suppressed the proliferation of HCC cells in vitro and in vivo, whereas downregulation of endogenous MARVELD1 by shRNAs significantly enhanced these characters. MARVELD1 overexpression could enhance chemosensitivity of HCC cells to epirubicin and 10-hydroxycamptothecin. Corresponding to these results, the expression of p-ERK1/2 and cyclin D1 were decreased, whereas p16 and p53 were increased in MARVELD1-transfected cells. We also demonstrated that knockdown of MARVELD1 resulted in upregulation of p-ERK1/2 and cyclin D1, and downregulation of p16 and p53. Moreover, the effect of the decreased cell growth rate was significantly reversed when MARVELD1-overexpressing cells were trasfected with p53 or p16 siRNA. Our findings suggest that MARVELD1 is a tumor suppressor by negatively regulating proliferation, tumor growth and chemosensitivity of HCC cells via increasing p53 and p16 in vitro and in vivo. MARVELD1 may be a potential target for HCC therapy. (Cancer Sci 2012; 103: 716722)

Identification of mouse MARVELD1 as a microtubule associated protein that inhibits cell cycle progression and migration

Identification and Characterization of MARVELD1, a Novel Nuclear Protein That is Down-Regulated in Multiple Cancers and Silenced by DNA Methylation.

Silence of MACC1 Decreases Cell Migration and Invasion in Human Malignant Melanoma Through Inhibiting the EMT.

MARVELD1 Regulates Integrin Β1-Mediated Cell Adhesion and Actin Organization Via Inhibiting Its Pre-Mrna Processing.

MARVELD1 inhibited cell proliferation and enhance chemosensitivity via increasing expression of p53 and p16 in hepatocellular carcinoma.

Импортин-β1играет Ключевую Роль В Процессе Ядерно-Цитоплазматического Транспорта MARVELD1

MARVELD1 interacting with catalase regulates reactive oxygen species metabolism and mediates the sensitivity to chemotherapeutic drugs in epithelial tumors of the reproductive system.

N-myc Downstream Regulated Gene 1 Inhibition of Tumor Progression in Caco2 Cells.

Marveld1 Modulates Cell Surface Morphology and Suppresses Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer

Identification of Interaction between MARVELD1 and Importin β1

Marveld1 Inhibits Nonsense-Mediated Rna Decay by Repressing Serine Phosphorylation of Upf1

Up-regulation of MARVEL Domain-Containing Protein 1 (MARVELD1) Accelerated the Malignant Phenotype of Glioma Cancer Cells Via Mediating JAK/STAT Signaling Pathway.

MARVELD1 depletion leads to dysfunction of motor and cognition via regulating glia-dependent neuronal migration during brain development

Abstract 2795: MARVELD1 Regulates Hypoxia-Induced Oxidative Stress Response and Tumor Growth

A Research of Intronic Mir-186 and Mir-335 Regulated by MARVELD1

Biological and Clinical Significance of Epigenetic Silencing of MARVELD1 Gene in Lung Cancer

Research advances in CKLF-like MARVEL transmembrane domain containing member 5]

The Tumor Suppressor CYLD Regulates Microtubule Dynamics and Plays a Role in Cell Migration

TMIGD1, a putative tumor suppressor, induces G2-M cell cycle checkpoint arrest in colon cancer cells

MAGI1, a Scaffold Protein with Tumor Suppressive and Vascular Functions

mDia2 is an important mediator of MRTF-A-dependent regulation of breast cancer cell migration